Skip to main content.

Eugene K. Lee, M.D., FACS

Eugene Lee portrait
Associate Professor, Urologic Surgery

Director, Division of Urologic Oncology, Division of Urologic Oncology, Urologic Surgery

elee@kumc.edu

Professional Background

Eugene Lee is an Associate Professor of Urology at the University of Kansas Health System. He serves as the Director of Urologic Oncology and the Program Director for the Fellowship. Additionally, he leads the Clinical Research program for the Department of Urology. After completion of his residency training at the University of Kansas, he completed a urologic oncology fellowship at the University of Texas, MD Anderson Cancer Center. Dr. Lee is a surgeon-scientist who focuses on urologic cancers. His main areas of expertise include bladder cancer, kidney cancer, penile cancer, and testicular cancer. He performs both open and minimally invasive surgery including robotic surgery.

Education and Training
  • BA, Liberal Arts, University of Missouri - Kansas City, Kansas City, MO
  • MD, Medicine, Univ of Missouri-Kansas City, Kansas City, MO
  • Internship, General Surgery, University of Missouri - Kansas City, Kansas City, MO
  • Residency, Urology, University of Kansas Medical Center, Kansas City, KS
  • Clinical Fellowship, Urologic Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX
Licensure, Accreditations & Certifications
  • American Board of Urology
  • KS State Medical license, Kansas State Board of Healing ARts
  • State of Missiouri, Division of Professional Registration Physician and Surgeon
Professional Affiliations
  • American Urological Association South Central Section, Board Member, 2025 - 2027
  • American Urological Association, Urologic Video Education Committee, Member, 2024 - 2026
  • Society of Urologic Oncology, SUO Fellowship Committee, Member, 2024 - 2026
  • Kansas Urologic Society, President, 2021 - 2023
  • Kansas Urologic Society, Treasurer, 2019 - 2021

Research

Overview

As a scientist, Dr. Lee's main area of interest is in improving outcomes in patients undergoing surgery for kidney and bladder cancer. Specifically, he has an interest in mobile health technology, patient education, and nutrition.